ELTP Elite Pharmaceuticals, Inc. $ELTP Company Overview
Stock Message Board http://investorshangout.com/search?q=ELTP&...mp;yt1=Go!
Last Updated: Sunday, March 30, 2014 8:37:54 PM
Elite Pharmaceuticals, Inc. ELTP Current Price and Quotes
Last Price 0.42
Previous Close 0.4245 Open 0.425
Daily Range 0.425 - 0.40 52wk Range 0.97 - 0.0631
Volume 1,699,632 Dividend N/A
Average Vol (3m) 7,394,522 Yield N/A
Elite Pharmaceuticals, Inc. ELTP
Company Information
165 Ludlow Avenue
Northvale, NJ 07647
Website: http://www.elitepharma.com
Phone: (201) 750-2646
Email: info@elitepharma.com
Elite Pharmaceuticals, Inc. ELTP
Elite Pharmaceuticals, Inc. ELTP
Financial Reportings and Disclosures
Reporting Status U.S. Reporting: SEC Filer
Audited Financials Not Available
Latest Report Dec 31, 2013 10-Q
CIK 0001053369
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: NV, USA
Year of Inc. Not Available
Employees Not Available
Company Officers/Contacts
Nasrat Hakim President, CEO
Carter J. Ward CFO
Company Directors
Jerry I. Treppel Chairman
Service Providers
Auditor/Accountant
Demetrius Berkower LLC
Wayne Plaza II
155 Route 46 West
Wayne, NJ, 07470
United States
Legal Counsel
Not Available
Investor Relations Firm
Not Available
Elite Pharmaceuticals, Inc. ELTP
ELTP Security Details
Share Structure
Market Value1 $221,374,481 a/o Mar 28, 2014
Shares Outstanding 527,082,097 a/o Feb 05, 2014
Float Not Available
Authorized Shares Not Available
Par Value 0.01
Shareholders
Shareholders of Record 122 a/o Jun 21, 2013
Security Notes
Note = delisted from NYSE Alternext on 05/21/09
Short Selling Data
Short Interest 350,447 (23.32%)
Mar 14, 2014
Significant Failures to Deliver No
Transfer Agent(s)
American Stock Transfer & Trust Company
Elite Pharmaceuticals, Inc. ELTP Financials
Period Ending Mar 31, 2013 Mar 31, 2012 Mar 31, 2011 Mar 31, 2010
Total Revenue 3,404 2,424 4,266 3,344
Cost of Revenue 2,315 1,014 2,675 2,306
Gross Profit 1,088 1,410 1,591 1,039
Operating Expenses
Research and Development 975 1,736 1,385 794
Sales, General and Admin. 1,559 1,435 918 1,966
Non-Recurring Items - - - -
Other 117 206 173 214
Operating Income (1,563) (1,966) (886) (1,936)
Income From Continuing Operations
Add'l Income/Expense Items 3,090 (12,922) (11,507) (4,589)
Earnings Before Interest and Tax 1,527 (14,888) (12,392) (6,786)
Interest Expense 393 654 1,491 1,271
Earnings Before Tax 1,134 (15,542) (13,884) (8,057)
Income Tax (354) (484) (301) -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations 1,488 (15,058) (13,582) (8,057)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income 1,488 (15,058) (13,582) (8,057)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders 1,488 (15,058) (13,582) (8,057)
Elite Pharmaceuticals, Inc. ELTP Recent News
Mar 27, 2014 Elite Pharmaceuticals Appoints Barbara Ellison as Vice President of Quality Operations and Regulatory Affairs
Mar 24, 2014 Elite Pharmaceuticals Announces Supplemental Application for Site Transfer of Isradipine
Mar 10, 2014 Elite Pharmaceuticals Expands Abuse Deterrent Technology Patent Portfolio Internationally
Mar 5, 2014 Elite Pharmaceuticals Reports Successful Pivotal Bioequivalence Study for Abuse Deterrent Product ELI-200
Feb 18, 2014 Elite Pharmaceuticals Reports Results of Pilot Bioequivalence Study for ELI-201
Feb 14, 2014 Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2014
Feb 10, 2014 Elite Pharmaceuticals, Inc. to Host Third Quarter Business Update Call on February 18, 2014
Feb 10, 2014 Elite Pharmaceuticals Analyst Report offers Insight and Market Data by BrokerBank Securities, Inc.
Jan 14, 2014 Elite Pharmaceuticals Initiates Pivotal Bioequivalence Study for Second Opioid Abuse Deterrent Product
ELTP Elite Pharmaceuticals, Inc. Research DD Guide
Stock Message Board http://investorshangout.com/search?q=ELTP&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/ELTP/quote
Stock Chart http://www.otcmarkets.com/stock/ELTP/chart
Company Info http://www.otcmarkets.com/stock/ELTP/company-info
Recent News http://www.otcmarkets.com/stock/ELTP/news
Financials http://www.otcmarkets.com/stock/ELTP/financials
Filings and Disclosure http://www.otcmarkets.com/stock/ELTP/filings
Short Sales http://www.otcmarkets.com/stock/ELTP/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/ELTP/insider-transactions
Research Reports http://www.otcmarkets.com/stock/ELTP/research
Summary http://finance.yahoo.com/q?s=ELTP
Historical Prices http://finance.yahoo.com/q/hp?s=ELTP+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=ELTP
Basic Chart http://finance.yahoo.com/q/bc?s=ELTP+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=ELTP+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=ELTP+Headlines
Press Releases http://finance.yahoo.com/q/p?s=ELTP+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=ELTP+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=ELTP+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=ELTP+Industry
Major Holders http://finance.yahoo.com/q/mh?s=ELTP+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=ELTP+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=ELTP+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=ELTP
Balance Sheet http://finance.yahoo.com/q/bs?s=ELTP
Cash Flow http://finance.yahoo.com/q/cf?s=ELTP+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/ELTP
Market Watch http://www.marketwatch.com/investing/stock/ELTP
Bloomberg http://www.bloomberg.com/quote/ELTP:US
Morningstar http://quotes.morningstar.com/stock/s?t=ELTP
Bussinessweek http://investing.businessweek.com/research/st...icker=ELTP
Barchart http://www.barchart.com/quotes/stocks/ELTP
OTC Short Report http://otcshortreport.com/index.php?index=ELTP
Investopedia http://www.investopedia.com/markets/stocks/ELTP/?wa=0
Stock Message Board http://investorshangout.com/search?q=ELTP&...mp;yt1=Go!
Last Updated: Sunday, March 30, 2014 8:37:54 PM
Elite Pharmaceuticals, Inc. ELTP Current Price and Quotes
Last Price 0.42
Previous Close 0.4245 Open 0.425
Daily Range 0.425 - 0.40 52wk Range 0.97 - 0.0631
Volume 1,699,632 Dividend N/A
Average Vol (3m) 7,394,522 Yield N/A
Elite Pharmaceuticals, Inc. ELTP
Company Information
165 Ludlow Avenue
Northvale, NJ 07647
Website: http://www.elitepharma.com
Phone: (201) 750-2646
Email: info@elitepharma.com
Elite Pharmaceuticals, Inc. ELTP
Elite Pharmaceuticals, Inc. ELTP
Financial Reportings and Disclosures
Reporting Status U.S. Reporting: SEC Filer
Audited Financials Not Available
Latest Report Dec 31, 2013 10-Q
CIK 0001053369
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: NV, USA
Year of Inc. Not Available
Employees Not Available
Company Officers/Contacts
Nasrat Hakim President, CEO
Carter J. Ward CFO
Company Directors
Jerry I. Treppel Chairman
Service Providers
Auditor/Accountant
Demetrius Berkower LLC
Wayne Plaza II
155 Route 46 West
Wayne, NJ, 07470
United States
Legal Counsel
Not Available
Investor Relations Firm
Not Available
Elite Pharmaceuticals, Inc. ELTP
ELTP Security Details
Share Structure
Market Value1 $221,374,481 a/o Mar 28, 2014
Shares Outstanding 527,082,097 a/o Feb 05, 2014
Float Not Available
Authorized Shares Not Available
Par Value 0.01
Shareholders
Shareholders of Record 122 a/o Jun 21, 2013
Security Notes
Note = delisted from NYSE Alternext on 05/21/09
Short Selling Data
Short Interest 350,447 (23.32%)
Mar 14, 2014
Significant Failures to Deliver No
Transfer Agent(s)
American Stock Transfer & Trust Company
Elite Pharmaceuticals, Inc. ELTP Financials
Period Ending Mar 31, 2013 Mar 31, 2012 Mar 31, 2011 Mar 31, 2010
Total Revenue 3,404 2,424 4,266 3,344
Cost of Revenue 2,315 1,014 2,675 2,306
Gross Profit 1,088 1,410 1,591 1,039
Operating Expenses
Research and Development 975 1,736 1,385 794
Sales, General and Admin. 1,559 1,435 918 1,966
Non-Recurring Items - - - -
Other 117 206 173 214
Operating Income (1,563) (1,966) (886) (1,936)
Income From Continuing Operations
Add'l Income/Expense Items 3,090 (12,922) (11,507) (4,589)
Earnings Before Interest and Tax 1,527 (14,888) (12,392) (6,786)
Interest Expense 393 654 1,491 1,271
Earnings Before Tax 1,134 (15,542) (13,884) (8,057)
Income Tax (354) (484) (301) -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations 1,488 (15,058) (13,582) (8,057)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income 1,488 (15,058) (13,582) (8,057)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders 1,488 (15,058) (13,582) (8,057)
Elite Pharmaceuticals, Inc. ELTP Recent News
Mar 27, 2014 Elite Pharmaceuticals Appoints Barbara Ellison as Vice President of Quality Operations and Regulatory Affairs
Mar 24, 2014 Elite Pharmaceuticals Announces Supplemental Application for Site Transfer of Isradipine
Mar 10, 2014 Elite Pharmaceuticals Expands Abuse Deterrent Technology Patent Portfolio Internationally
Mar 5, 2014 Elite Pharmaceuticals Reports Successful Pivotal Bioequivalence Study for Abuse Deterrent Product ELI-200
Feb 18, 2014 Elite Pharmaceuticals Reports Results of Pilot Bioequivalence Study for ELI-201
Feb 14, 2014 Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2014
Feb 10, 2014 Elite Pharmaceuticals, Inc. to Host Third Quarter Business Update Call on February 18, 2014
Feb 10, 2014 Elite Pharmaceuticals Analyst Report offers Insight and Market Data by BrokerBank Securities, Inc.
Jan 14, 2014 Elite Pharmaceuticals Initiates Pivotal Bioequivalence Study for Second Opioid Abuse Deterrent Product
ELTP Elite Pharmaceuticals, Inc. Research DD Guide
Stock Message Board http://investorshangout.com/search?q=ELTP&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/ELTP/quote
Stock Chart http://www.otcmarkets.com/stock/ELTP/chart
Company Info http://www.otcmarkets.com/stock/ELTP/company-info
Recent News http://www.otcmarkets.com/stock/ELTP/news
Financials http://www.otcmarkets.com/stock/ELTP/financials
Filings and Disclosure http://www.otcmarkets.com/stock/ELTP/filings
Short Sales http://www.otcmarkets.com/stock/ELTP/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/ELTP/insider-transactions
Research Reports http://www.otcmarkets.com/stock/ELTP/research
Summary http://finance.yahoo.com/q?s=ELTP
Historical Prices http://finance.yahoo.com/q/hp?s=ELTP+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=ELTP
Basic Chart http://finance.yahoo.com/q/bc?s=ELTP+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=ELTP+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=ELTP+Headlines
Press Releases http://finance.yahoo.com/q/p?s=ELTP+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=ELTP+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=ELTP+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=ELTP+Industry
Major Holders http://finance.yahoo.com/q/mh?s=ELTP+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=ELTP+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=ELTP+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=ELTP
Balance Sheet http://finance.yahoo.com/q/bs?s=ELTP
Cash Flow http://finance.yahoo.com/q/cf?s=ELTP+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/ELTP
Market Watch http://www.marketwatch.com/investing/stock/ELTP
Bloomberg http://www.bloomberg.com/quote/ELTP:US
Morningstar http://quotes.morningstar.com/stock/s?t=ELTP
Bussinessweek http://investing.businessweek.com/research/st...icker=ELTP
Barchart http://www.barchart.com/quotes/stocks/ELTP
OTC Short Report http://otcshortreport.com/index.php?index=ELTP
Investopedia http://www.investopedia.com/markets/stocks/ELTP/?wa=0
